TRPV1 and acute kidney injury: By the same token, the activation of TRPV1, TRPV4, TRPC6, and TRPM2 on rodent models of AKI following ischemia–reperfusion promotes renoprotection through regional vasodilation [16], an observation which might endorse these surface proteins as potential therapeutic targets for ischemic AKI.